Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer

Background - The improved efficacy of tyrosine kinase inhibitors (TKI) mandates reappraisal of local therapy (LT) for brain metastases (BM) of oncogene-driven non-small-cell lung cancer (NSCLC). - Patients and methods - This study included all epidermal growth factor receptor-mutated (EGFR+, n = 108...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: El-Shafie, Rami (VerfasserIn) , Seidensaal, Katharina (VerfasserIn) , Bozorgmehr, Farastuk (VerfasserIn) , Kazdal, Daniel (VerfasserIn) , Eichkorn, Tanja (VerfasserIn) , Elshiaty, Mariam (VerfasserIn) , Weber, D. (VerfasserIn) , Allgäuer, Michael (VerfasserIn) , König, Laila (VerfasserIn) , Uzun-Lang, Kristin (VerfasserIn) , Forster, Tobias (VerfasserIn) , Arians, Nathalie (VerfasserIn) , Rieken, Stefan (VerfasserIn) , Heußel, Claus Peter (VerfasserIn) , Herth, Felix (VerfasserIn) , Thomas, Michael (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Christopoulos, Petros (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2 June 2021
In: ESMO open
Year: 2021, Jahrgang: 6, Heft: 3, Pages: 1-10
ISSN:2059-7029
DOI:10.1016/j.esmoop.2021.100161
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.esmoop.2021.100161
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2059702921001216
Volltext
Verfasserangaben:R.A. El Shafie, K. Seidensaal, F. Bozorgmehr, D. Kazdal, T. Eichkorn, M. Elshiaty, D. Weber, M. Allgäuer, L. König, K. Lang, T. Forster, N. Arians, S. Rieken, C.-P. Heussel, F.J. Herth, M. Thomas, A. Stenzinger, J. Debus & P. Christopoulos

MARC

LEADER 00000caa a2200000 c 4500
001 1766790097
003 DE-627
005 20240414193258.0
007 cr uuu---uuuuu
008 210813s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.esmoop.2021.100161  |2 doi 
035 |a (DE-627)1766790097 
035 |a (DE-599)KXP1766790097 
035 |a (OCoLC)1341420486 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
084 |a 33  |2 sdnb 
100 1 |a El-Shafie, Rami  |d 1989-  |e VerfasserIn  |0 (DE-588)110057378X  |0 (DE-627)859521427  |0 (DE-576)469743859  |4 aut 
245 1 0 |a Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer  |c R.A. El Shafie, K. Seidensaal, F. Bozorgmehr, D. Kazdal, T. Eichkorn, M. Elshiaty, D. Weber, M. Allgäuer, L. König, K. Lang, T. Forster, N. Arians, S. Rieken, C.-P. Heussel, F.J. Herth, M. Thomas, A. Stenzinger, J. Debus & P. Christopoulos 
264 1 |c 2 June 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.08.2021 
520 |a Background - The improved efficacy of tyrosine kinase inhibitors (TKI) mandates reappraisal of local therapy (LT) for brain metastases (BM) of oncogene-driven non-small-cell lung cancer (NSCLC). - Patients and methods - This study included all epidermal growth factor receptor-mutated (EGFR+, n = 108) and anaplastic lymphoma kinase-rearranged (ALK+, n = 33) TKI-naive NSCLC patients diagnosed with BM in the Thoraxklinik Heidelberg between 2009 and 2019. Eighty-seven patients (62%) received early LT, while 54 (38%) received delayed (n = 34; 24%) or no LT (n = 20; 14%). LT comprised stereotactic (SRT; n = 40; 34%) or whole-brain radiotherapy (WBRT; n = 77; 66%), while neurosurgical resection was carried out in 19 cases. - Results - Median overall survival (OS) was 49.1 months for ALK+ and 19.5 months for EGFR+ patients (P = 0.001), with similar median intracranial progression-free survival (icPFS) (15.7 versus 14.0 months, respectively; P = 0.80). Despite the larger and more symptomatic BM (P < 0.001) of patients undergoing early LT, these experienced longer icPFS [hazard ratio (HR) 0.52; P = 0.024], but not OS (HR 1.63; P = 0.12), regardless of the radiotherapy technique (SRT versus WBRT) and number of lesions. High-risk oncogene variants, i.e. non-del19 EGFR mutations and ‘short’ EML4-ALK fusions (mainly variant 3, E6:A20), were associated with earlier intracranial progression (HR 2.97; P = 0.001). The longer icPFS with early LT was also evident in separate analyses of the EGFR+ and ALK+ subsets. - Conclusions - Despite preferential use for cases with poor prognostic factors, early LT prolongs the icPFS, but not OS, in TKI-treated EGFR+/ALK+ NSCLC. Considering the lack of survival benefit, and the neurocognitive effects of WBRT, patients presenting with polytopic BM may benefit from delaying radiotherapy, or from radiosurgery of multiple or selected lesions. For SRT candidates, the improved tumor control with earlier radiotherapy should be weighed against the potential toxicity and the enhanced intracranial activity of newer TKI. High-risk EGFR/ALK variants are associated with earlier intracranial failure and identify patients who could benefit from more aggressive management. 
650 4 |a ALK NSCLC 
650 4 |a brain metastases 
650 4 |a EGFR NSCLC 
650 4 |a stereotactic radiotherapy 
650 4 |a whole-brain radiotherapy 
700 1 |a Seidensaal, Katharina  |d 1987-  |e VerfasserIn  |0 (DE-588)1084643685  |0 (DE-627)848624483  |0 (DE-576)456394869  |4 aut 
700 1 |a Bozorgmehr, Farastuk  |d 1979-  |e VerfasserIn  |0 (DE-588)141921811  |0 (DE-627)632526734  |0 (DE-576)326848150  |4 aut 
700 1 |a Kazdal, Daniel  |d 1983-  |e VerfasserIn  |0 (DE-588)114929650X  |0 (DE-627)1009614088  |0 (DE-576)496635867  |4 aut 
700 1 |a Eichkorn, Tanja  |e VerfasserIn  |0 (DE-588)1191801187  |0 (DE-627)167027666X  |4 aut 
700 1 |a Elshiaty, Mariam  |e VerfasserIn  |0 (DE-588)1237666333  |0 (DE-627)1764596110  |4 aut 
700 1 |a Weber, D.  |e VerfasserIn  |4 aut 
700 1 |a Allgäuer, Michael  |e VerfasserIn  |0 (DE-588)1178366790  |0 (DE-627)1049312597  |0 (DE-576)517751453  |4 aut 
700 1 |a König, Laila  |d 1986-  |e VerfasserIn  |0 (DE-588)1053640579  |0 (DE-627)790403315  |0 (DE-576)409584282  |4 aut 
700 1 |a Uzun-Lang, Kristin  |d 1986-  |e VerfasserIn  |0 (DE-588)106868237X  |0 (DE-627)820592064  |0 (DE-576)428008569  |4 aut 
700 1 |a Forster, Tobias  |d 1986-  |e VerfasserIn  |0 (DE-588)1102961132  |0 (DE-627)860567028  |0 (DE-576)470399430  |4 aut 
700 1 |a Arians, Nathalie  |d 1986-  |e VerfasserIn  |0 (DE-588)1035620782  |0 (DE-627)74879199X  |0 (DE-576)383388600  |4 aut 
700 1 |a Rieken, Stefan  |d 1979-  |e VerfasserIn  |0 (DE-588)135553385  |0 (DE-627)567062570  |0 (DE-576)278641725  |4 aut 
700 1 |a Heußel, Claus Peter  |e VerfasserIn  |0 (DE-588)1048631389  |0 (DE-627)780769422  |0 (DE-576)40288146X  |4 aut 
700 1 |a Herth, Felix  |e VerfasserIn  |0 (DE-588)1016095236  |0 (DE-627)705477568  |0 (DE-576)351509925  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
773 0 8 |i Enthalten in  |t ESMO open  |d [London] : Elsevier, 2016  |g 6(2021), 3, Artikel-ID 100161, Seite 1-10  |h Online-Ressource  |w (DE-627)84705344X  |w (DE-600)2844985-X  |w (DE-576)454658516  |x 2059-7029  |7 nnas  |a Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer 
773 1 8 |g volume:6  |g year:2021  |g number:3  |g elocationid:100161  |g pages:1-10  |g extent:10  |a Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer 
856 4 0 |u https://doi.org/10.1016/j.esmoop.2021.100161  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2059702921001216  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210813 
992 |a 20210813 
993 |a Article 
993 |a Article 
994 |a 2021 
994 |a 2021 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 19  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 18 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 17 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |e 50000PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 16 
998 |g 1016095236  |a Herth, Felix  |m 1016095236:Herth, Felix  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1016095236  |e 950000PH1016095236  |e 950900PH1016095236  |e 50000PH1016095236  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 15 
998 |g 1048631389  |a Heußel, Claus Peter  |m 1048631389:Heußel, Claus Peter  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1048631389  |e 950000PH1048631389  |e 950900PH1048631389  |e 50000PH1048631389  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 14 
998 |g 135553385  |a Rieken, Stefan  |m 135553385:Rieken, Stefan  |d 50000  |e 50000PR135553385  |k 0/50000/  |p 13 
998 |g 1035620782  |a Arians, Nathalie  |m 1035620782:Arians, Nathalie  |d 910000  |d 911400  |e 910000PA1035620782  |e 911400PA1035620782  |k 0/910000/  |k 1/910000/911400/  |p 12 
998 |g 1102961132  |a Forster, Tobias  |m 1102961132:Forster, Tobias  |d 910000  |d 911400  |e 910000PF1102961132  |e 911400PF1102961132  |k 0/910000/  |k 1/910000/911400/  |p 11 
998 |g 106868237X  |a Uzun-Lang, Kristin  |m 106868237X:Uzun-Lang, Kristin  |d 910000  |d 911400  |e 910000PU106868237X  |e 911400PU106868237X  |k 0/910000/  |k 1/910000/911400/  |p 10 
998 |g 1053640579  |a König, Laila  |m 1053640579:König, Laila  |d 910000  |d 911400  |e 910000PK1053640579  |e 911400PK1053640579  |k 0/910000/  |k 1/910000/911400/  |p 9 
998 |g 1178366790  |a Allgäuer, Michael  |m 1178366790:Allgäuer, Michael  |d 910000  |d 912000  |e 910000PA1178366790  |e 912000PA1178366790  |k 0/910000/  |k 1/910000/912000/  |p 8 
998 |g 1191801187  |a Eichkorn, Tanja  |m 1191801187:Eichkorn, Tanja  |d 910000  |d 911400  |e 910000PE1191801187  |e 911400PE1191801187  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 114929650X  |a Kazdal, Daniel  |m 114929650X:Kazdal, Daniel  |d 910000  |d 912000  |e 910000PK114929650X  |e 912000PK114929650X  |k 0/910000/  |k 1/910000/912000/  |p 4 
998 |g 141921811  |a Bozorgmehr, Farastuk  |m 141921811:Bozorgmehr, Farastuk  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PB141921811  |e 950000PB141921811  |e 950900PB141921811  |e 50000PB141921811  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 3 
998 |g 1084643685  |a Seidensaal, Katharina  |m 1084643685:Seidensaal, Katharina  |d 910000  |d 911400  |e 910000PS1084643685  |e 911400PS1084643685  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 110057378X  |a El-Shafie, Rami  |m 110057378X:El-Shafie, Rami  |d 50000  |e 50000PE110057378X  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1766790097  |e 3968010841 
999 |a KXP-PPN1766790097  |e 3967982041 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Rami","family":"El-Shafie","display":"El-Shafie, Rami","role":"aut"},{"family":"Seidensaal","display":"Seidensaal, Katharina","role":"aut","given":"Katharina"},{"given":"Farastuk","display":"Bozorgmehr, Farastuk","role":"aut","family":"Bozorgmehr"},{"given":"Daniel","display":"Kazdal, Daniel","role":"aut","family":"Kazdal"},{"role":"aut","display":"Eichkorn, Tanja","family":"Eichkorn","given":"Tanja"},{"family":"Elshiaty","display":"Elshiaty, Mariam","role":"aut","given":"Mariam"},{"family":"Weber","display":"Weber, D.","role":"aut","given":"D."},{"given":"Michael","display":"Allgäuer, Michael","role":"aut","family":"Allgäuer"},{"family":"König","display":"König, Laila","role":"aut","given":"Laila"},{"family":"Uzun-Lang","role":"aut","display":"Uzun-Lang, Kristin","given":"Kristin"},{"given":"Tobias","family":"Forster","display":"Forster, Tobias","role":"aut"},{"given":"Nathalie","family":"Arians","role":"aut","display":"Arians, Nathalie"},{"display":"Rieken, Stefan","role":"aut","family":"Rieken","given":"Stefan"},{"given":"Claus Peter","display":"Heußel, Claus Peter","role":"aut","family":"Heußel"},{"given":"Felix","display":"Herth, Felix","role":"aut","family":"Herth"},{"display":"Thomas, Michael","role":"aut","family":"Thomas","given":"Michael"},{"given":"Albrecht","family":"Stenzinger","display":"Stenzinger, Albrecht","role":"aut"},{"given":"Jürgen","family":"Debus","display":"Debus, Jürgen","role":"aut"},{"given":"Petros","display":"Christopoulos, Petros","role":"aut","family":"Christopoulos"}],"id":{"eki":["1766790097"],"doi":["10.1016/j.esmoop.2021.100161"]},"origin":[{"dateIssuedDisp":"2 June 2021","dateIssuedKey":"2021"}],"name":{"displayForm":["R.A. El Shafie, K. Seidensaal, F. Bozorgmehr, D. Kazdal, T. Eichkorn, M. Elshiaty, D. Weber, M. Allgäuer, L. König, K. Lang, T. Forster, N. Arians, S. Rieken, C.-P. Heussel, F.J. Herth, M. Thomas, A. Stenzinger, J. Debus & P. Christopoulos"]},"title":[{"title":"Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer","title_sort":"Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"84705344X","corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"note":["Gesehen am 13.06.24"],"part":{"issue":"3","volume":"6","extent":"10","text":"6(2021), 3, Artikel-ID 100161, Seite 1-10","year":"2021","pages":"1-10"},"id":{"zdb":["2844985-X"],"issn":["2059-7029"],"eki":["84705344X"]},"origin":[{"publisher":"Elsevier ; BMJ","publisherPlace":"[London] ; London","dateIssuedKey":"2016","dateIssuedDisp":"2016-"}],"name":{"displayForm":["European Society for Medical Oncology"]},"disp":"Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancerESMO open","title":[{"title_sort":"ESMO open","title":"ESMO open","subtitle":"cancer horizons"}],"language":["eng"],"pubHistory":["1.2016 -"]}],"recId":"1766790097","physDesc":[{"extent":"10 S."}],"language":["eng"],"note":["Gesehen am 13.08.2021"]} 
SRT |a ELSHAFIERAEFFECTOFTI2202